Malaysia

104,700 courses of Paxlovid available for Covid-19 patients: MoH

Drug to be offered for free at CACs, government hospitals, says health minister

Updated 4 years ago · Published on 14 Apr 2022 6:10PM

104,700 courses of Paxlovid available for Covid-19 patients: MoH
Health Minister Khairy Jamaluddin says the Pfizer Covid-19 drug Paxlovid will be offered to treat Categories 2 and 3 patients above the ages of 18 who do not require oxygen therapy and are at risk of experiencing severe symptoms. – AFP pic, April 14, 2022

by Arjun Mohanakrishnan

KUALA LUMPUR – Pfizer’s Covid-19 drug Paxlovid will be offered for free after the Health Ministry has obtained 104,700 courses recently.

In a press conference in the Parliament building today, Health Minister Khairy Jamaluddin said Paxlovid will only be available at Covid-19 Assessment Centres (CACs) and government hospitals.

Some 48,000 courses arrived in Malaysia on April 9 and have been sent to 14 locations in the country, with more to be delivered to Sabah and Sarawak tomorrow.

“These deliveries involve 481 CAC health clinics and 15 government hospitals.”

He said the Drug Control Authority on March 3 gave a conditional approval for Paxlovid, adding that the medication will reduce the virus’ ability to replicate itself and improve the body’s immune system to fight the infection.

Paxlovid will be offered to treat Categories 2 and 3 Covid-19 patients above the ages of 18 who do not require oxygen therapy and are at risk of experiencing severe symptoms.

Covid-19 patients that arrive at CACs or government hospitals will be screened and assessed by a medical officer before receiving the drug.

Patients that are given a score above three during the assessment will be given priority for the antiviral treatment.

“Priority will be given to senior citizens infected with Covid-19, patients with various comorbidities and the immunocompromised.”

He said the drug must be taken within five days of experiencing symptoms for optimum efficacy and patients must take two pills a day for a period of five days.

He added that Paxlovid can reduce deaths and hospitalisation by up to 90%, but it should not be used to replace Covid-19 vaccinations. – The Vibes, April 14, 2022

Related News

Malaysia / 3mth

Covid-19 cases in Malaysia stable, no deaths recorded this year – MOH

Malaysia / 6mth

Bad move to channel EPF dividends into Account 3 for festive withdrawals, cautions economist

Opinion / 10mth

A tale of two administrations: How Warisan and GRS shaped Sabah’s future

Malaysia / 1y

MOH closely monitoring Covid-19 amid rising cases in neighbouring countries

Opinion / 1y

The Trump dilemma and reclaiming balance: The urgent need for fair global trade

Culture & Lifestyle / 1y

Renowned public health expert honoured at award ceremony in Penang

Spotlight

Opinion

“I’m not a war criminal, I’m a patriot”: Shavendra Silva’s amnesia tour meets the receipts

By Abbi Kanthasamy

Malaysia

British management on trial – does a royal management institute deliver value?

Malaysia

Doctor among five killed in Sarawak Flying Doctor helicopter crash identified

Malaysia

Nearly 10,000 potential fire hotspots detected on RSPO-managed land

Malaysia

Undang Yang Empat produces letter allegedly confirming Tuanku Muhriz’s removal

Malaysia

Northern Malaysia must prepare for the consequences of lower rainfall

Malaysia

Helicopter crashes during flying doctor service mission in Sarawak

You may be interested

Malaysia

Energy reform key to investment, jobs and growth - Economy Minister

Malaysia

Najib house arrest bid may be decided on Sept 11

Malaysia

PH says rule of law must prevail in high-profile corruption cases

By Alfian Z.M. Tahir

Malaysia

Undang Yang Empat produces letter allegedly confirming Tuanku Muhriz’s removal

Malaysia

Vellfire driver charged with four counts of attempted murder

Malaysia

Negeri Sembilan MB silent on alleged Ruler removal letter

Malaysia

Abdul Azeez, 2 former TH officials remanded for 2 days

Malaysia

Proclamation to remove Tuanku Muhriz invalid, says Undang

By Alfian Z.M. Tahir